David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.